Latest Regulatory Clearance News

Orpheus Uranium has secured key regulatory approvals for advanced exploration across multiple projects and raised $4.37 million, including a cornerstone investment from IsoEnergy, as it prepares for a busy 2026 drilling season.

Insignia Financial Limited will be removed from the S&P/ASX 200 Index ahead of its acquisition by Daintree BidCo, with 4DMedical Limited stepping in on April 20, 2026.

Insignia Financial shareholders met on 13 April 2026 and overwhelmingly backed a $4.80 per share acquisition scheme by CC Capital, valuing the company at about $3.3 billion and offering a near 57% premium to pre-offer prices.

Diatreme Resources is consolidating its Far North Queensland silica assets by selling the Cape Flattery Silica Project to its joint venture with Sibelco, securing $7.4 million in fresh capital and streamlining project ownership ahead of key development milestones.

Insignia Financial has received Foreign Investment Review Board approval for its proposed acquisition by Daintree BidCo, clearing a key regulatory hurdle. The scheme now awaits shareholder and court approvals, with the board recommending shareholder support.

National Storage REIT (ASX:NSR) has confirmed satisfaction of key foreign investment conditions for its proposed acquisition by a Brookfield-GIC consortium, with securityholder meetings scheduled for mid-April.

Arafura Rare Earths has locked in binding cornerstone equity agreements worth approximately A$230 million with German and Australian government-backed funds, advancing the financing of its Nolans Rare Earths Project.

Atomo Diagnostics stands to gain significantly as Lumos Diagnostics’ FebriDx test secures FDA CLIA waiver approval, vastly expanding its US market potential. This regulatory milestone triggers substantial contracted revenues and prompts Atomo to ramp up production.

Boab Metals has received the crucial regulatory green light for its Sorby Hills project, clearing the way for full-scale mining operations and first concentrate production targeted in late 2027.

Firebrick Pharma has secured its first regulatory approval for Nasodine Nasal Spray in Indonesia, paving the way for entry into Southeast Asia’s largest market. This milestone marks a significant step in the company’s international expansion strategy.

Iceni Gold Limited has successfully raised $1.55 million to advance exploration at its flagship 14 Mile Well project and has acquired a significant tenement package near the Granny Smith mine, positioning itself for growth in Western Australia's premier gold district.

Neometals Ltd has released a positive scoping study for its Ironclad gold deposit at the Barrambie Gold Project, outlining a rapid production pathway with potential output of up to 11,000 ounces of gold within a year.